Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland

Status Completed

Clinical Trial Summary

Until positive results were found with oral naltrexone, no medication has been effective against amphetamine dependence. The primary aim of this pilot study is to replicate the findings of the Swedish team that showed oral Naltrexone prevented relapse to amphetamine addiction and to extend their results by randomizing treatment-seeking amphetamine addicted patients to a 6 month course of VIVITROL (naltrexone for extended-release injectable suspension) or VIVITROL placebo. Patients in each group will receive drug counseling. VIVITROL is administered monthly and may be a better test of efficacy than tablets that must be taken daily.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01100853
Study type	Interventional
Source	University of Pennsylvania
Contact
Status	Completed
Phase	Phase 3
Start date	May 2010
Completion date	February 2013

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00600145` - Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward	N/A
Completed	`NCT00377299` - A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence	N/A
Recruiting	`NCT02541526` - Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia	Phase 3
Active, not recruiting	`NCT02541513` - An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence	Phase 3
Completed	`NCT02774954` - Change the Cycle: An RCT to Prevent Injection Initiation	N/A
Active, not recruiting	`NCT00123370` - Trial of Modafinil for Methamphetamine Dependence	Phase 2
Not yet recruiting	`NCT01273701` - Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence	N/A
Completed	`NCT00833443` - Study of Medical Treatment for Methamphetamine Addiction	Phase 2
Active, not recruiting	`NCT00630097` - A Dose Ranging Study of Modafinil for Methamphetamine Dependence	Phase 2
Recruiting	`NCT02541500` - An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence	Phase 3